prognosis

You have access
High MCM6 Expression as a Potential Prognostic Marker in Clear-cell Renal Cell Carcinoma
NU-RI JANG, JINA BAEK, YOUNGHWII KO, PHIL HYUN SONG and MI-JIN GU

In Vivo January 2021, 35 (1) 299-306; DOI: https://doi.org/10.21873/invivo.12259
You have access
ATM Expression as a Prognostic Marker in Patients With Advanced Biliary Tract Cancer Treated With First-line Gemcitabine and Platinum Chemotherapy
HYERA KIM, SEUNG TAE KIM, KWAI HAN YOO, JUNG YONG HONG, YOUNG SUK PARK, HO YEONG LIM and JOON OH PARK

In Vivo January 2021, 35 (1) 499-505; DOI: https://doi.org/10.21873/invivo.12284
You have access
Clinical Significance of Tumor and Immune Cell PD-L1 Expression in Gastric Adenocarcinoma
DONG HYUN KIM, GO EUN BAE, KWANG SUN SUH, DAVID RYUMAN, KYU SANG SONG, JU SEOK KIM, SANG-IL LEE and MIN-KYUNG YEO

In Vivo November 2020, 34 (6) 3171-3180; DOI: https://doi.org/10.21873/invivo.12152
You have access
Impact of Surgical Resection on Metachronous Metastases of Colorectal Cancer According to Tumor Doubling Time
HIROAKI MIYAKE, KOJI MURONO, KAZUSHIGE KAWAI, HIROAKI NOZAWA, HARUFUMI MAKI, KIYOSHI HASEGAWA, JUN NAKAJIMA and SOICHIRO ISHIHARA

In Vivo November 2020, 34 (6) 3367-3374; DOI: https://doi.org/10.21873/invivo.12175
You have access
Clinical Significance of Prognostic Nutritional Index in the Treatment of Esophageal Squamous Cell Carcinoma
KOJI TAKAO, HIROTAKA KONISHI, HITOSHI FUJIWARA, ATSUSHI SHIOZAKI, KATSUTOSHI SHODA, TOSHIYUKI KOSUGA, TAKESHI KUBOTA, TOMOHIRO ARITA, RYO MORIMURA, YASUTOSHI MURAYAMA, YOSHIAKI KURIU, HISASHI IKOMA, MASAYOSHI NAKANISHI, KAZUMA OKAMOTO and EIGO OTSUJI

In Vivo November 2020, 34 (6) 3451-3457; DOI: https://doi.org/10.21873/invivo.12184
You have access
Oncological Outcomes of Pathological T1 Lower Rectal Cancer Patients With or Without Preoperative Chemoradiotherapy
TETSURO TAIRA, HIROAKI NOZAWA, KAZUSHIGE KAWAI, KAZUHITO SASAKI, KOJI MURONO, MANABU KANEKO, SHIGENOBU EMOTO, YUUKI IIDA, HIROAKI ISHII, YUICHIRO YOKOYAMA, HIROYUKI ANZAI, HIROFUMI SONODA and SOICHIRO ISHIHARA

In Vivo November 2020, 34 (6) 3559-3564; DOI: https://doi.org/10.21873/invivo.12199
You have access
A Novel Systemic Inflammatory Score Combined With Immunoinflammatory Markers Accurately Reflects Prognosis in Patients With Esophageal Cancer
TAKAFUMI SUZUKI, YUSUKE ISHIBASHI, HIRONORI TSUJIMOTO, SHINSUKE NOMURA, KEITA KOUZU, YUJIRO ITAZAKI, TAKAO SUGIHARA, MANABU HARADA, NOZOMI ITO, HIDEKAZU SUGASAWA, YOJI KISHI and HIDEKI UENO

In Vivo November 2020, 34 (6) 3705-3711; DOI: https://doi.org/10.21873/invivo.12218
You have access
Prognostic Value of CD63 Expression in Solid Tumors: A Meta-analysis of the Literature
HYUN MIN KOH, BO GUN JANG and DONG CHUL KIM

In Vivo September 2020, 34 (5) 2209-2215; DOI: https://doi.org/10.21873/invivo.12031
You have access
Hepatocellular Carcinoma-associated microRNAs Induced by Hepatoma-derived Growth Factor Stimulation
HIRAYUKI ENOMOTO, HIDEJI NAKAMURA, HIROKI NISHIKAWA, TAKASHI NISHIMURA, YOSHINORI IWATA, SHUHEI NISHIGUCHI and HIROKO IIJIMA

In Vivo September 2020, 34 (5) 2297-2301; DOI: https://doi.org/10.21873/invivo.12041
You have access
High Paip1 Expression as a Potential Prognostic Marker in Hepatocellular Carcinoma
HAYEON KIM, WONKYUNG JUNG, AEREE KIM, HAN KYEOM KIM and BAEK-HUI KIM

In Vivo September 2020, 34 (5) 2491-2497; DOI: https://doi.org/10.21873/invivo.12065

Main menu

User menu

Search

prognosis

Pages